Category: News

How intimate partner violence affects women living with HIV

A global study released last year revealed alarming figures concerning women living with HIV and violence. Among 945 women living with HIV from 94 countries who participated in the study, 89 per cent reported having experienced or feared violence before, since and/or because of their HIV diagnosis. Violence they experienced was reported to be higher after HIV diagnosis from their intimate partner and others in their social network.

Read more

National survey reveals information habits of people living with HIV

From its beginning, CATIE has shared information with people living with HIV so that they can take better care of their health. In Fall 2015, we undertook a national online survey to better understand the information needs of people living with HIV today. The survey results may confirm what you already know about your clients’ information needs. Or perhaps they contain a surprise or two. Whatever the case, the results help guide all of us in how we can best serve our clients.

Read more

Trois points à retenir de la Conférence AFRAVIH 2016

L’AFRAVIH est une conférence scientifique, organisée tous les deux ans par l’Alliance francophone des acteurs de santé contre le VIH. Elle avait lieu cette année du 20 au 23 avril à Bruxelles, rassemblant plus d’un millier de participants, venus d’Europe, d’Afrique, d’Asie ou d’Amérique du Nord. L’AFRAVIH ouvre un espace de débat francophone unique pour les acteurs de la lutte contre le VIH et les hépatites virales. La conférence est l’occasion de discuter avec des intervenants très divers, issus du milieu communautaire, de la recherche ou de la santé publique. Difficile de faire le tri dans un programme aussi riche… Mais voici trois points à retenir de la conférence!

Read more

Health Canada’s statement on the status of naloxone is a welcome drug policy paradigm shift

The administration of naloxone, a chemical compound that effectively temporarily reverses the effects of an opioid overdose, is recommended by the World Health Organization to be used in the case of an opioid overdose. Naloxone is currently available in Canada only in an injectable form and by prescription only; it can only be administered to the person named on the prescription, not to a third party.

Read more